A criterion-based audit of the technical quality of external beam radiotherapy for prostate cancer

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 339-345

  Brundage, Michael ^a,b   Danielson, Brita ^c   Pearcey, Robert ^c   Bass, Brenda ^a   Pickles, Tom ^d   Bahary, Jean Paul ^e   Peng, Yingwei ^a   Wallace, David ^a   MacKillop, William ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Prostate cancer; Quality indicators; Quality of care; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE SCINTISCANNING; CANADA; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RETROSPECTIVE STUDY; SEXUAL FUNCTION; TOTAL QUALITY MANAGEMENT;

PROSTATE CANCER; QUALITY INDICATORS; QUALITY OF CARE; RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84881480037     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.023     Document Type: Article

References (41)

1. J.A. Hayman Measuring the quality of care in radiation oncology Semin Radiat Oncol 18 2008 201 206
2. B. Danielson, M. Brundage, and R. Pearcey Development of indicators of the quality of radiotherapy for localized prostate cancer Radiother Oncol 99 2011 29 36
3. W. Mackillop Health services research in radiation oncology: toward achieving the achievable for patients with cancer L.L. Gunderson, J.E. Tepper, Clinical radiation oncology 2nd ed. 2007 Elsevier-Churchill Livingstone Philadelphia 215 237
4. A. Donabedian The quality of care. How can it be assessed? JAMA 260 1998 1743 1748
5. A. Donabedian Evaluating the quality of medical care Milbank Q. 44 1966 206
6. J.B. Owen, J.R. White, M.J. Zelefsky, and J.F. Wilson Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer J Am Coll Radiol 6 2009 442 447
7. C.D. Shaw Criterion based audit BMJ 300 1990 649 651
8. Canadian Cancer Society Statistics Canada, Provincial/Territorial Cancer Registries, Public Health Agency of Canada Can Cancer Stat 2012
9. M. Kerba, Q. Miao, J. Zhang-Salomons, and W. Mackillop Defining the need for prostate cancer radiotherapy in the general population: a criterion-based benchmarking approach Clin Oncol-UK 22 2010 801 809
10. F. Foroudi, S. Tyldesley, L. Barbera, J. Huang, and W.J. Mackillop Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer Int J Radiat Oncol Biol Phys 55 2003 51 63
11. H. Lukka Prostate cancer: risk categories and role of hormones and radiotherapy Can J Urol 9 2002 9
12. C.E. Bogan, and M.J. English Benchmarking for best practices: winning through innovative adaptation 1994 McGraw-Hill (NY) USA
13. N.W. Weissman, J.J. Allison, and C.I. Kiefe Achievable benchmarks of care: the ABCs of benchmarking J Eval Clin Pract 5 1999 269 281
14. W.E. Golden, R.C. Hermann, M. Jewell, and C. Brewster Development of evidence-based performance measures for bipolar disorder: overview of methodology J Psychiatr Pract 14 2008 18 30
15. SAS-statistical software [computer program]. Version 9.3 2012.
16. L. Cionini, G. Gardani, and P. Gabriele Quality indicators in radiotherapy Radiother Oncol 82 2007 191 200
17. D.C. Miller, and C.S. Saigal Quality of care indicators for prostate cancer: progress toward consensus Urol Oncol 27 2009 427 434
18. D.C. Miller, B.A. Spencer, and J. Ritchey Treatment choice and quality of care for men with localized prostate cancer Med. Care 45 2007 401 409
19. B.A. Spencer, D.C. Miller, and M.S. Litwin Variations in quality of care for men with early-stage prostate cancer J Clin Oncol 26 2008 Aug 3735 3742
20. J.D. Birkmeyer, Y. Sun, A. Goldfaden, N.J. Birkmeyer, and T.A. Stukel Volume and process of care in high-risk cancer surgery Cancer 106 2006 2476 2481
21. L.M. Ellison, B.J. Trock, N.R. Poe, and A.W. Partin The effect of hospital volume on cancer control after radical prostatectomy J Urol 173 2005 2094 2098
22. M. Ma, J. Bell, S. Campbell, I. Basnett, A. Pollock, and I. Taylor Breast cancer management: is volume related to quality? Clinical advisory panel Br J Cancer 75 1997 1652 1659
23. C.G. Gourin, and K.D. Frick National trends in oropharyngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care Laryngoscope 122 2012 543 551
24. C.G. Gourin, and K.D. Frick National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care Laryngoscope 122 2012 88 94
25. M.A. Elferink, P. Krijnen, and M.W. Wouters Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands Eur J Surg Oncol 36 2010 S74 S82
26. A.B. Chen, A.V. D'Amico, B.A. Neville, E.W. Steyerberg, and C.C. Earle Provider case volume and outcomes following prostate brachytherapy J Urol 181 2009 113 118
27. A. Sandhu, R. Sethi, and R. Rice Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy Radiother Oncol 88 2008 20 25
28. C. Udrescu, P. Jalade, B.B. De, G. Michel-Amadry, and O. Chapet Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers Radiother Oncol 103 2012 266 269
29. S.L. Tucker, J.M. Michalski, and W.R. Bosch Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06 Radiother Oncol 104 2012 109 113
30. F. Buettner, S.L. Gulliford, S. Webb, M.R. Sydes, D.P. Dearnaley, and M. Partridge The dose-response of the anal sphincter region-an analysis of data from the MRC RT01 trial Radiother Oncol 103 2012 347 352
31. J.A. Hatton, P.B. Greer, and C. Tang Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans Radiother Oncol 98 2011 162 168
32. C. Cozzarini, C. Fiorino, and M.N. Di Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer Radiother Oncol 84 2007 164 170
33. J.S. Wu, P.M. Brasher, and A. El-Gayed Phase II study of hypofractionated image-guided radiotherapy for localized prostate cancer: outcomes of 55 Gy in 16 fractions at 3.4 Gy per fraction Radiother Oncol 103 2012 210 216
34. R. Valdagni, A.E. Nahum, and T. Magnani Long-term biochemical control of prostate cancer after standard or hyper-fractionation: evidence for different outcomes between low-intermediate and high risk patients Radiother Oncol 101 2011 454 459
35. H.D. Thames, D. Kuban, and L.B. Levy The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995 Radiother Oncol 96 2010 6 12
36. J.L. Nijman, H. Sixma, T.B. Van, R.B. Keus, and M. Hendriks The quality of radiation care: the results of focus group interviews and concept mapping to explore the patient's perspective Radiother Oncol 102 2012 154 160
37. Cancer Care Ontario-Radiation Treatment Wait Times. 2012. https://www.cancercare.on.ca/ocs/wait-times/radiationwt/.
38. British Columbia Cancer Agency-Wait time Targets. 2012. http://www.health.gov.bc.ca/swt/overview/waittime-targets.html.
39. L.E. Schnipper, T.J. Smith, and D. Raghavan American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology J Clin Oncol 30 2012 1715 1724
40. Cancer Institute-NSW Pilot Accreditation Program. 2012. http://www.cancerinstitute.org.au/issue-1/cancer-services-pilot-accreditation- program.
41. NHS-National Institute for Health and Clinical Excellence (NICE) - prostate cancer diagnosis and treatment guidance. 2012. http://www.nice.org.uk/ nicemedia/pdf/CG58NICEGuideline.pdf.